Neutralization mechanisms of two highly potent antibodies against human enterovirus 71

Neutralization mechanisms of two highly potent antibodies against human enterovirus 71

Εμφάνιση άλλων εκδόσεων (1)

Despite significant advances in health care, outbreaks of infections by enteroviruses (EVs) continue to plague the Asia-Pacific region every year. Enterovirus 71 (EV71) causes hand-foot-and-mouth disease (HFMD), for which there are currently no therapeutics. Here, we report two new antibodies, A9 an...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Zhu, L, Xu, K, Wang, N, Cao, L, Wu, J, Gao, Q, Fry, E, Stuart, D, Rao, Z, Wang, J, Wang, X
Μορφή:	Journal article
Έκδοση:	American Society for Microbiology 2018

Παρόμοια τεκμήρια

Neutralization mechanisms of two highly potent antibodies against human enterovirus 71
ανά: Zhu, L, κ.ά.
Έκδοση: (2018)

Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71
ανά: Ling Zhu, κ.ά.
Έκδοση: (2018-09-01)

Neutralizing Antibodies to Enterovirus 71 in Belém, Brazil
ανά: Maria de Lourdes C Gomes, κ.ά.
Έκδοση: (2002-01-01)

Short-term dynamic changes in neutralizing antibodies against enterovirus 71 after vaccination
ανά: Shenyu Wang, κ.ά.
Έκδοση: (2020-07-01)

Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16.
ανά: Kelly, J, κ.ά.
Έκδοση: (2015)

Unexpected mode of engagement between enterovirus 71 and its receptor SCARB2
ανά: Zhou, D, κ.ά.
Έκδοση: (2018)

Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
ανά: Hyun Ju In, κ.ά.
Έκδοση: (2018-01-01)

A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71
ανά: Wang, X, κ.ά.
Έκδοση: (2012)

A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71.
ανά: Wang, X, κ.ά.
Έκδοση: (2012)

Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection.
ανά: Xiao Fang Lim, κ.ά.
Έκδοση: (2012-01-01)

Assessment of the Level of Virus Neutralizing Antibodies to Enterovirus 71 in Children in Ekaterinburg (2010–2017)
ανά: O. M. Olenkova, κ.ά.
Έκδοση: (2019-05-01)

Is a monovalent vaccine against enterovirus 71 sufficient? A review of enterovirus 71 vaccine development based on enterovirus surveillance in Taiwan
ανά: Shu-Chun Chu, κ.ά.
Έκδοση: (2013-09-01)

Exploration of the in vitro Antiviral Effects and the Active Components of Changyanning Tablets Against Enterovirus 71
ανά: Ge Q, κ.ά.
Έκδοση: (2024-03-01)

Enterovirus 71 Maternal Antibodies in Infants, Taiwan
ανά: Shu-Ting Luo, κ.ά.
Έκδοση: (2009-04-01)

Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody.
ανά: Xiaohua Ye, κ.ά.
Έκδοση: (2016-03-01)

Enterovirus 71 Meningoencephalitis
ανά: J Gordon Millichap
Έκδοση: (1999-02-01)

Enterovirus 71 Meningoencephalitis
ανά: J Gordon Millichap
Έκδοση: (1999-02-01)

Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71
ανά: Kuan-Ying A. Huang, κ.ά.
Έκδοση: (2020-10-01)

VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment
ανά: Fang-Hong Chen, κ.ά.
Έκδοση: (2019-11-01)

Outbreaks of enterovirus 71 infection
ανά: AbuBakar, Sazaly, κ.ά.
Έκδοση: (2000)

Engineering a novel IgG-like bispecific antibody against enterovirus A71
ανά: Hsiang-Ching Wang, κ.ά.
Έκδοση: (2020-12-01)

Antibody dependent enhancement infection of Enterovirus 71 <it>in vitro </it>and <it>in vivo</it>
ανά: Qin E-De, κ.ά.
Έκδοση: (2011-03-01)

Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.
ανά: Mei-Liang Huang, κ.ά.
Έκδοση: (2013-01-01)

Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications
ανά: Zhu Liye, κ.ά.
Έκδοση: (2011-06-01)

Development of Novel Vaccines against Enterovirus-71
ανά: Pinn Tsin Isabel Yee, κ.ά.
Έκδοση: (2015-12-01)

Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.
ανά: Xingui Tian, κ.ά.
Έκδοση: (2012-01-01)

Targeting Ser78 phosphorylation of Hsp27 achieves potent antiviral effects against enterovirus A71 infection
ανά: Mandi Wu, κ.ά.
Έκδοση: (2024-12-01)

The Immungenicity and Cross-Neutralizing Activity of Enterovirus 71 Vaccine Candidate Strains
ανά: Xia Xiao, κ.ά.
Έκδοση: (2021-08-01)

A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein.
ανά: Tanja K Kiener, κ.ά.
Έκδοση: (2014-01-01)

In vivo time-related evaluation of a therapeutic neutralization monoclonal antibody against lethal enterovirus 71 infection in a mouse model.
ανά: Zhiqun Li, κ.ά.
Έκδοση: (2014-01-01)

Receptors for enterovirus 71
ανά: Seiya Yamayoshi, κ.ά.
Έκδοση: (2014-01-01)

Correction: Protection against Enterovirus 71 with Neutralizing Epitope Incorporation within Adenovirus Type 3 Hexon
Έκδοση: (2012-01-01)

Correction: Protection against Enterovirus 71 with Neutralizing Epitope Incorporation within Adenovirus Type 3 Hexon.
ανά: Xingui Tian, κ.ά.
Έκδοση: (2012-01-01)

COPI is required for enterovirus 71 replication.
ανά: Jianmin Wang, κ.ά.
Έκδοση: (2012-01-01)

Antiviral Effect of Matrine against Human Enterovirus 71
ανά: Jiangning Liu, κ.ά.
Έκδοση: (2012-08-01)

Neutralizing antibodies against enteroviruses in patients with hand, foot and mouth disease
ανά: Nguyet, LA, κ.ά.
Έκδοση: (2020)

Anti-Enterovirus 71 Agents of Natural Products
ανά: Liyan Wang, κ.ά.
Έκδοση: (2015-09-01)

Milrinone in Enterovirus 71 Brain Stem Encephalitis
ανά: SHIH-MIN eWANG, κ.ά.
Έκδοση: (2016-03-01)

The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children.
ανά: Qunying Mao, κ.ά.
Έκδοση: (2013-01-01)

Enterovirus 71 CNS Infection and ADHD
ανά: J Gordon Millichap
Έκδοση: (2008-09-01)